In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.
PAGE Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the publication of the results of a clinical study conducted by Prof. Nicola Aceto ...
PAGE Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the publication of the results ...
11d
PAGE Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the ...
CLASS data FOR NOVEL APPROACH TO CANCER treatmentParsortix system used to identify patients with highly metastatic CTC clusters for targeted treatmentNew treatment strategy provides 'uncharted ...
V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization.
A recent study by a team from Chiba University has demonstrated a promising approach for fighting antibiotic resistance by identifying a compound, V-161, that inhibits a sodium-pumping enzyme critical ...
The P382S mutation of LRD6-6 in spl-A impairs its ATPase activity and disrupts its interaction with ESCRT-III subunits OsSNF7.1/7.2/7.3 In summary, our study reveals that the conserved amino acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback